|

FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin) Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since May 2026

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Fudan University1
  • Crossignal Therapeutics, Inc.1

Indications

  • Colorectal Cancer2
  • Cancer2
  • Pancreatic Ductal Adenocarcinoma1
  • ctDNA1
  • Solid Tumor, Adult1

Other1 trial

Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer
Phase 2

Houston, Texas1 trial

A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

MD Anderson Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.